Impact of complement and difference of cell-based assay and ELISA in determination of neutralization capacity against mumps and measles virus.
CCID(50) neutralization assay
Complement
ELISA
Mumps virus
Neutralizing titer
Journal
Journal of immunological methods
ISSN: 1872-7905
Titre abrégé: J Immunol Methods
Pays: Netherlands
ID NLM: 1305440
Informations de publication
Date de publication:
03 2021
03 2021
Historique:
received:
07
08
2020
revised:
29
12
2020
accepted:
31
12
2020
pubmed:
8
1
2021
medline:
15
9
2021
entrez:
7
1
2021
Statut:
ppublish
Résumé
Neutralizing antibodies against mumps and measles virus are considered a correlate of protection against these diseases. Measurement of neutralizing antibodies is mostly performed using plaque reduction neutralization assay or 50% cell culture infective dose (CCID
Identifiants
pubmed: 33412172
pii: S0022-1759(21)00002-8
doi: 10.1016/j.jim.2021.112957
pii:
doi:
Substances chimiques
Antibodies, Neutralizing
0
Complement System Proteins
9007-36-7
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
112957Informations de copyright
Copyright © 2021. Published by Elsevier B.V.